Calderasib (MK-1084) is a selective KRAS G12C inhibitor. Calderasib exhibits anticancer activity and can be used either alone or in combination with Pembrolizumab (HY-P9902) for cancer research[1].
Molecular Weight:
637.08
Purity:
99.82
CAS Number:
[2641216-67-1]
Formula:
C32H31ClF2N6O4
Target:
Ras
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted